Trial Profile
A study to evaluate risk of severe hypoglycaemia associated with use of basal insulin therapy (NPH), Insulin glargine and Insulin detemir in working adults
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Mar 2016
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary) ; Insulin suspension isophane
- Indications Diabetes mellitus; Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- 21 Mar 2016 New trial record